Steven Cohen’s Satellos Bioscience MSLE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.8M Sell
681,800
-900
-0.1% -$8.38K 0.01% 1712
2026
Q2
$5.31M Sell
682,700
-8,078
-1% -$55.5K 0.01% 1712
2026
Q1
$3.89M Buy
+690,778
New +$6.79M 0.01% 1873

Other funds holding MSLE

Steven Cohen's MSLE Position: Q3 2026 in Review

Steven Cohen reduced its Satellos Bioscience (MSLE) stake by 0.13% in Q3 2026, selling an estimated $8.38K and leaving 681,800 shares worth $5.8M. The position accounts for 0.01% of the portfolio, ranked #1712.

Steven Cohen first reported a position in MSLE in Q1 2026 and has held it in 3 quarters since. 30 funds tracked by Wall St. Rank hold MSLE as of Q3 2026.

  • Steven Cohen held 681,800 shares of Satellos Bioscience worth $5.8M as of Q3 2026.
  • Steven Cohen sold 900 Satellos Bioscience shares in Q3 2026, an estimated $8.38K.
  • Satellos Bioscience made up 0.01% of Steven Cohen's portfolio in Q3 2026, its #1712 holding.
  • Steven Cohen first reported a position in Satellos Bioscience in Q1 2026 and has held it in 3 quarters since.
  • 30 funds tracked by Wall St. Rank held Satellos Bioscience as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.